Puma Biotechnology Inc expected to post earnings of 10 cents a share - Earnings Preview

Puma Biotechnology

25/02/2025 21:20

Puma Biotechnology Inc PBYI.OQ PBYI.O is expected to show a fall in quarterly revenue when it reports  results on February 27 for the period ending December 31 2024

The Los Angeles California-based  company is expected to report a 27.3% decrease in revenue to $52.5 million from $72.2 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Puma Biotechnology Inc is for earnings of 10 cents per share.

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Puma Biotechnology Inc is $4.00​, above​ its last closing price of $2.89. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
0.34
0.35
0.41
Beat
16.9
Jun. 30 2024
-0.13
-0.13
-0.09
Beat
30.6
Mar. 31 2024
-0.22
-0.22
-0.10
Beat
53.8​
Dec. 31 2023
0.32
0.30
0.26
Missed
-13.2
​​Sep. 30 2023
0.08
0.08
0.12
Beat
56.5
Jun. 30 2023
0.01
0.01
0.05
Beat
566.7​
Mar. 31 2023
-0.07
-0.07
0.03
Beat
142.9
Dec. 31 2022
0.05
0.05
-0.12
Missed
-340

This summary was machine generated February 25 at 21:20 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)